Antiepileptic-related AEs increase total costs in outpatients Clinical study 14 November 2020 Pages: 3 - 3
Ceritinib valuable treatment option in advanced ALK-positive lung cancer Clinical study 14 November 2020 Pages: 4 - 4
Childhood 'flu vaccination: health and economic benefits in Germany Clinical study 14 November 2020 Pages: 5 - 5
Childhood cancer therapies cost effective in sub-Saharan Africa Clinical study 14 November 2020 Pages: 6 - 6
Collaboration on polypharmacy reduces readmission and costs of care Clinical study 14 November 2020 Pages: 7 - 7
Community paramedicine programme for seniors value for money Non-clinical study 14 November 2020 Pages: 8 - 8
Dapagliflozin is cost effective for HF with reduced ejection fraction in China Clinical study 14 November 2020 Pages: 9 - 9
Decisions by ICER and NICE discordant for some cancer drugs Clinical study 14 November 2020 Pages: 10 - 10
Depression care for US prostate cancer patients: more QALYs, lower cost Clinical study 14 November 2020 Pages: 11 - 11
Direct oral anticoagulants good value for stroke prevention in AF Clinical study 14 November 2020 Pages: 12 - 12
Early detection high-value approach to improving outcomes in COPD Clinical study 14 November 2020 Pages: 13 - 13
Estimation of CE threshold based on health opportunity costs in USA Clinical study 14 November 2020 Pages: 14 - 14
Factors influencing HTA decisions differ between countries Clinical study 14 November 2020 Pages: 15 - 15
Global access to orphan drugs: disparities in policies Clinical study 14 November 2020 Pages: 16 - 16
HPV vaccination more cost effective in younger than older patients Clinical study 14 November 2020 Pages: 17 - 17
Including rucaparib in US payer formulary has little budget impact Clinical study 14 November 2020 Pages: 18 - 18
Informal care for patients with AF substantial burden Non-clinical study 14 November 2020 Pages: 19 - 19
Inhaler-to-nebuliser therapeutic interchange saves hospital cost Clinical study 14 November 2020 Pages: 20 - 20
Is population genomic screening for breast/ovarian cancer cost effective? Clinical study 14 November 2020 Pages: 21 - 21
Lenvatinib cost effective in advanced liver cancer in Australia Clinical study 14 November 2020 Pages: 22 - 22
Little concordance in CE evaluations between USA and UK Clinical study 14 November 2020 Pages: 23 - 23
Model valid to assess health/cost impact of Ryan White HIV/AIDS Program Clinical study 14 November 2020 Pages: 24 - 24
Non-invasive prenatal Down syndrome screening "affordable" in Canada Clinical study 14 November 2020 Pages: 25 - 25
Potentially inappropriate drugs increase healthcare use and costs Clinical study 14 November 2020 Pages: 26 - 26
Rising cost of immunisation needs resource mobilisation at global level Non-clinical study 14 November 2020 Pages: 27 - 27
Total hip arthroplasty "extremely cost effective" for hip osteoarthritis Review 14 November 2020 Pages: 28 - 28
Transfat elimination in foods: health gains at acceptable cost in Australia Non-clinical study 14 November 2020 Pages: 29 - 29
Treatment preferences examined in cancer patients with financial distress Clinical study 14 November 2020 Pages: 30 - 30
Tyrosine kinase inhibitors in CML: better outcomes, lower hospital cost Clinical study 14 November 2020 Pages: 31 - 31
Value of 4CMenB infant vaccination in England re-examined Clinical study 14 November 2020 Pages: 32 - 32
Wellness program a win for chronically ill US patients Clinical study 14 November 2020 Pages: 33 - 33
NICE consulting on methods used for health technology evaluation News item 14 November 2020 Pages: 34 - 34
NICE recommends liraglutide & venetoclax + obinutuzumab, but not nivolumab News item 14 November 2020 Pages: 35 - 35